Oral Drug Delivery Resources

  1. Is My Molecule Suitable For An Orally Disintegrating Tablet?

    Innovations in drug delivery formats are enabling more patient-centric treatments and helping to boost patient compliance. Learn about the advances being developed to expand ODT technology.

  2. An Integrated Radiolabelled Study: Determine Mass Balance Metabolite Profile & Absolute Bioavailability 3/3/2022

    The study assessed the absorption and disposition of nolasiban after oral and IV administrations and enabled determination of mass balance, routes and rates of excretion and metabolism and absolute bioavailability.

  3. How Various Clinical Study Stages Influence Oral Formulation Approach 4/6/2022

    It’s important for pharmaceutical and biopharmaceutical companies to implement a phase-appropriate approach for early formulation development and later-stage commercial development.

  4. Sophisticated Formulation Approaches For Insoluble Drug Candidates 1/24/2022

    A sophisticated drug delivery approach involves collaboration, technical experience, and years of working knowledge in drug development at different stages of the process.

  5. Reformulation Of A Complex, High-Drug-Load, Modified Release Dosage Form 4/5/2021

    What if you could limit and position a formulation change as only a CMC prior approval supplement under the FDA’s scale-up and post-approval changes guidance?

  6. Crystallization Process Development: Peptide Crystallization 1/24/2022

    Whether performed during formation of an API or as a means to purify intermediates, achieving control of nucleation and crystal growth is critical to designing a successful peptide crystallization process.

  7. Development Of Next Gen Sustained Release Solutions For Pain Management 2/22/2023

    A TheraPEA™ polymer based injectable formulation designed to deliver the same dose of Triamcinolone Acetonide (TAA) as in Zilretta® has shown promising results in a series of pre-clinical studies.

  8. How Oral GLP-1 Therapies Are Revolutionizing Obesity Treatment 2/3/2025

    The rising incidence and severity of obesity have amplified a therapeutic need in healthcare. Read more about Dr. Srinivasan Shanmugam discussing the challenges and impact of GLP-1 analogs.

  9. Are Drugs Becoming More Lipophilic Over Time?

    Get a deeper look into how drug lipophilicity has evolved over time, its impact on drug development, and the need for new technology to enable new more complex drugs.

  10. Developing An Effective Lipid Nanoparticle Formulation Process For Small Molecule And Biologicals Delivery 3/1/2022

    Lipid nanoparticles (LNPs) are a versatile formulation technology used by drug development teams to deliver a variety of small/large molecules, peptides, and biologicals.